12 results
10-K
2020 FY
PRAX
Praxis Precision Medicines Inc
17 Mar 21
Annual report
8:33am
legislation designed to, among other things, bring more transparency to drug pricing, reduce the cost of prescription drugs under Medicare, review … product access and marketing cost disclosure and transparency measures and, in some cases, designed to encourage importation from other countries
DRS
410dsg6
22 Jul 20
Draft registration statement
12:00am
S-1
spt6bx
25 Sep 20
IPO registration
5:19pm
S-1/A
vt1u4c6
9 Oct 20
IPO registration (amended)
6:09am
424B4
x6espqji3s5
16 Oct 20
Prospectus supplement with pricing info
4:02pm
10-Q
d4wbyp
23 Nov 20
Quarterly report
4:16pm
DRS/A
mfsyx ia3v
28 Aug 20
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next